Table 1.
Variables | Cases (n = 703) | Controls (n = 685) | P a | ||
---|---|---|---|---|---|
n | % | n | % | ||
Age (years) | 0.745 | ||||
<57 | 352 | 50.1 | 337 | 49.2 | |
≥ 57 | 351 | 49.9 | 348 | 50.8 | |
Sex | 0.882 | ||||
Female | 170 | 24.2 | 168 | 24.5 | |
Male | 533 | 75.8 | 517 | 75.5 | |
Race | |||||
Caucasians | 647 | 92.0 | 647 | 94.5 | 0.066 |
Others | 56 | 8.0 | 38 | 5.5 | |
Asian | 5 | 0.7 | 1 | 0.1 | |
Black | 30 | 4.3 | 16 | 2.3 | |
Hispanic | 19 | 2.7 | 21 | 3.1 | |
American Indian | 2 | 0.3 | 0 | 0.0 | |
Smoking statusb | < 0.001 | ||||
Never | 250 | 35.6 | 363 | 53.2 | |
Former | 223 | 31.8 | 255 | 37.3 | |
Current | 229 | 32.6 | 65 | 9.5 | |
Ever | 452 | 64.4 | 320 | 46.9 | |
Alcohol useb | <0.0001 | ||||
Never | 187 | 26.6 | 294 | 43.1 | |
Former | 181 | 25.8 | 137 | 20.1 | |
Current | 334 | 47.6 | 252 | 36.9 | |
Ever | 515 | 73.4 | 389 | 57.0 | |
Tumor siteb | |||||
Oropharynx | 367 | 52.3 | |||
Non-oropharynxc | 335 | 47.7 | |||
T staged | |||||
T1 | 201 | 28.7 | |||
T2 | 260 | 37.0 | |||
T3 | 123 | 17.5 | |||
T4 | 118 | 16.8 | |||
N staged | |||||
N0 | 232 | 33.0 | |||
N1 | 77 | 11.0 | |||
N2 | 381 | 54.3 | |||
N3 | 12 | 1.7 | |||
Overall staged | |||||
I | 97 | 13.8 | |||
II | 72 | 10.3 | |||
III | 101 | 14.4 | |||
IV | 432 | 61.5 |
Two-sided χ2 test.
Missed 1 patients’ and 2 controls’ information.
Included oral cavity (n=214), hypopharyngeal (n=20) and larynx (n=101) cancer cases.